Gracell Biotechnologies News

GRCLDelisted Stock  USD 4.02  0.26  6.07%   
About 61% of Gracell Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Gracell Biotechnologies suggests that many traders are alarmed regarding Gracell Biotechnologies' prospects. Gracell Biotechnologies' investing sentiment shows overall attitude of investors towards Gracell Biotechnologies.
  
over six months ago at businesswire.com         
GRCL Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Gracell Biotechnologies Inc. ...
businesswire News
over six months ago at barrons.com         
These Stocks Are Moving the Most Today Gracell, Ansys, NIO, Manchester United, and More
Barrons News
over six months ago at barrons.com         
AstraZeneca to Acquire Gracell in 1.2 Billion Deal to Further Cell Therapy Goals
Barrons News
over six months ago at marketwatch.com         
Gracell ADSs Take Flight Premarket on 1.2B Takeover by AstraZeneca
marketwatch News
over six months ago at benzinga.com         
AstraZeneca Bolsters Cell Therapy Pipeline With Over 1B Deal For China-Based Gracell Biotechnologies
benzinga news
over six months ago at finance.yahoo.com         
AstraZeneca Bolsters Cell Therapy Pipeline With Over 1B Deal For China-Based Gracell Biotechnologies
Yahoo News
over six months ago at benzinga.com         
Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies
benzinga news
over six months ago at benzinga.com         
Crude Oil Rises Over 3 US Home Prices Increase In October
benzinga news
over six months ago at news.google.com         
AstraZeneca to Buy Gracell Biotechnologies for 1.2 Billion - Morningstar
Google News at Macroaxis
over six months ago at globenewswire.com         
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 12 Clinical Tri...
Macroaxis News: globenewswire.com
over six months ago at zacks.com         
Gracell Biotechnologies Inc. Sponsored ADR Is a Great Choice for Trend Investors, Heres Why
zacks News
over six months ago at benzinga.com         
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 12 Clinical Tri...
benzinga news
over six months ago at news.google.com         
Gracell Biotechnologies Inc. Short Interest Update - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Gracell Biotechnologies that are available to investors today. That information is available publicly through Gracell media outlets and privately through word of mouth or via Gracell internal channels. However, regardless of the origin, that massive amount of Gracell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Gracell Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Gracell Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Gracell Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Gracell Biotechnologies alpha.

Gracell Biotechnologies Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Gracell Stock

If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
CEOs Directory
Screen CEOs from public companies around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance